Company lists
The Los Angeles edition · 2026

Life sciencescompanies in Los Angeles

Life science tools, genomics, oncology, medical devices, nutraceuticals and more: the companies building life sciences in Los Angeles, California, with their founders, funding, team size and business models.

286 company profiles79 with recorded fundingNovember 2026 edition
Los Angeles · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent life sciences business events in Los Angeles

Funding, M&A, contract wins and launches involving 391 life sciences companies in Los Angeles, last 24 months: 24 M&A deals · 10 funding rounds · 7 Contracts. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: May 2026.

M&AAcquisition · Completed

Standard dental labs acquires BRLIT Dental Laboratory

Standard Dental Labs has completed its acquisition of BRLIT Dental Laboratory, a Sarasota‑based lab with nearly five decades of history, marking a major milestone in the company's…

Dental Laboratory
FundingSeries C

Aneuvo

ANEUVO, a medical device startup developing neuromodulation implants for spinal cord injury, announced a $22 million Series C to accelerate clinical development of its implantable therapy.

Investors Catcher Technology, New investors
Medical Devices
M&AAcquisition · Announced

Kairos pharma acquires Celyn Therapeutics, Inc.

Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics

Biotechnology
FundingRegistered offering

Immix biopharma

Immix Biopharma, Inc. ... net proceeds to Immix from the offering, after deducting the underwriting discounts, commissions and other offering expenses, were approximately $93.7 million.

Biotechnology
Funding

Pelage pharmaceuticals

Two startups — Pelage Pharmaceuticals and Veradermics — raised a combined $270 million to develop treatments for a common form of hair loss, known clinically as androgenetic alopecia.

Investors GV
Biotechnology
M&AAcquisition · Announced

Standard dental labs acquires Dream Dentistry Labs, LLC

Standard Dental Labs Inc. today announced that it has signed a binding agreement on November 4th, 2025 to acquire Dream Dentistry Labs, LLC.

Dental laboratory
FundingVenture capital

The plug drink

The Plug Drink, a Los Angeles-based liver health supplement brand, raised $5 million in equity and debt in venture capital.

Investors Korean Venture Funds
Liver health
M&AAcquisition · Completed

MannKind Corporation acquires Scpharmaceuticals

MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.

Biopharmaceutical
M&AMerger · Announced

MannKind Corporation acquires Scpharmaceuticals

On August 24, 2025, scPharmaceuticals entered into a merger agreement with MannKind Corporation, which will acquire all outstanding shares of scPharmaceuticals through a tender offer.

M&AAcquisition · Announced

Generous Brands acquires Health-ade

Generous Brands, the parent company of Bolthouse Farms and Evolution Fresh, has signed a deal to acquire kombucha maker Health-Ade, expanding its presence in the functional beverage market.

Kombucha
M&AAcquisition · Pending

Concentra Biosciences acquires Acelyrin

Acelyrin, Alumis boards approve merger: The companies fended off a takeover attempt by Kevin Tang's Concentra Biosciences and now expect to complete the deal sometime in the second quarter.

M&AMerger · Pending

Alumis acquires Acelyrin

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company ... today announced that its stockholders voted to…

Biopharmaceutical
M&AAcquisition · Announced

Concentra Biosciences acquires Acelyrin

Concentra in late February came in between the planned merger, offering to scoop up Acelyrin for $3 per share, which would total about $300 million, versus its trade price of $2.17 at…

M&AMerger · Announced

Alumis acquires Acelyrin

Alumis Inc. (Nasdaq: ALMS) ... and ACELYRIN, INC. (Nasdaq: SLRN) ... have jointly filed a definitive proxy statement/prospectus with the U.S. Securities and Exchange Commission in…

Biopharmaceutical
ContractTechnology

Renovaro Biosciences · client: Predictive oncology

Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today provided an update…

TechBio
FundingPrivate placement

Aadi bioscience

Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer…

Investors Ally bridge group, Orbimed, Invus, Kalehua Capital
Oncology therapeutics
M&AMerger · Announced

Acelyrin acquires Alumis

ACELYRIN, INC. ... determined that the unsolicited indication of interest from Concentra Biosciences, LLC, ... is not reasonably expected to result in a superior proposal to the planned…

M&AAcquisition · Announced

Concentra acquires Acelyrin

"Acelyrin (SLRN) "confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP is the controlling shareholder, to…

M&AAcquisition · Completed

Safe supply streaming acquires Safety Strips

Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) (“ Safe Supply ” or the “ Company “) and Safety Strips Tech Corp., a private company (“ SSTC ” or “ Safety Strips “)…

Healthcare
M&AMerger · Announced

Acelyrin acquires Alumis

Two weeks ago, Acelyrin announced it had entered into a definitive agreement to merge with fellow immune player Alumis.

FundingPrivate placement

Cougar biotechnology

In its second private placement this year, Cougar Biotechnology Inc. raised gross proceeds of $87 million to support its cancer clinical trials.

Investors Leerink swann llc, Cowen and Co. LLC, Lazard Frères & Co. LLC
Biotechnology
FundingPrivate placement

Response Genetics

Response Genetics (Los Angeles), a company focused on the development of molecular diagnostic tests for cancer, reported raising $4 million from a private placement of newly issued…

Diagnostics
FundingPublic offering

Kite pharma

Kite Pharma Inc. priced a public offering of about 3.6 million shares at $69 per share for gross proceeds of about $250.1 million.

Investors Na
M&AMerger · Completed

Cougar biotechnology acquires SRKP 4 Inc.

In news released today, the Los Angeles-based company merged with public shell SRKP 4 Inc., creating a public entity in which Cougar stockholders hold 100 percent of the equity.

Biopharmaceuticals
M&AAcquisition · Announced

Celera acquires Berkeley Heart Lab

Celera (Rockville, Maryland), a business of Applera (Norwalk, Connecticut), yesterday reported an agreement to purchase cardiovascular healthcare company Berkeley Heart Lab (BHL;…

Healthcare
M&AAcquisition · Completed

Celera acquires Berkeley HeartLab

Celera (Alameda, California) reported completing the acquisition of Berkeley HeartLab (BHL; Burlingame, California) for about $195 million in cash.

Cardiovascular healthcare
ContractSupply

Capricor therapeutics · client: Nippon shinyaku

Capricor will receive an up-front payment of $20 million. Capricor will handle development and manufacturing duties for deramiocel while Nippon Shinyaku will be responsible for the sales…

Pharmaceutical
ContractTechnology

Response Genetics · client: Hitachi chemical

Response Genetics Inc., of Los Angeles, said Hitachi Chemical Co. Ltd., of Tokyo, will begin using the company's techniques to extract genetic information from formalin-fixed…

Biotechnology

Life sciences companies in Los Angeles, by funding and team

Few life sciences companies in Los Angeles, California publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 286 active companies.

Showing 25 of 50

Developer of drugs for immunology

Immunology
US$550.00mSeries C · Sep 2022
24+33% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
6 yr2020
0none in 3 months

Developer of antibody-based therapeutics for the treatment of cancer

Oncology
US$412.30mSeries C · Oct 2025
64LinkedIn · Jul 2026
Fee-for-service
7 yr2019
—No postings tracked

Developer of multimodal brain measurement technology for neuromedicine

Wearable technology
US$158.25mSeries C · Nov 2023
56LinkedIn · Jul 2026
Subscription
10 yr2016
—No postings tracked

Developing phage therapeutics to combat antibiotic-resistant bacterial infections

Infectious diseases
US$154.50mSeries D · Dec 2016
60+5% 12 mo to Dec 2021recorded Dec 2021
Physical commerce
20 yr2006
0none in 3 months

Developer of therapeutics for hair loss treatment in men and women

Dermatology
US$150.80mSeries B · Sep 2025
15LinkedIn · Jul 2026
E-commerce - product / Physical commerce
8 yr2018
0none in 3 months

Provider of human cell interaction platform for drug discovery

Genomics
US$110.00mSeries B · Apr 2022
68+3% 12 mo to Dec 2023LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months

Human milk-based nutrition for vulnerable infants, improving health outcomes

Nutraceuticals tech
US$97.88mSeries E · May 2018
327-14% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
27 yr1999
0none in 3 months · last posted Dec 2025

Developer of miniature robots for drug delivery

Drug delivery
US$63.20mSeries B · Nov 2022
24+2% vs previous recordLinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months

Developer of tyrosine kinase inhibitor for the treatment of breast cancer

Women health
US$60.00mSeries C · Dec 2011
260-26% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
16 yr2010
0none in 3 months · last posted Jun 2026

Immune imaging technology for cancer and autoimmune disease management

Imaging diagnostics
US$59.64mSeries C · Jun 2021
12+31% 12 mo to Dec 2022LinkedIn · Jul 2026
Physical commerce
19 yr2007
0none in 3 months

Developer of cell therapies

Diversified pharmaceuticals
US$52.00mSeries A · May 2021
14-9% vs previous recordLinkedIn · Jul 2026
Physical commerce / Subscription
6 yr2020
0none in 3 months

Developer of small-molecule drugs

Drug delivery
US$50.00mSeries B · Jan 2004
858+35% 12 mo to Sep 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
35 yr1991
0none in 3 months · last posted Jun 2026

AI-based solutions for pathological image analysis

Life sciences tech
US$48.83mSeries B · Jan 2025
40+81% vs previous recordLinkedIn · Jul 2026
Subscription
7 yr2019
0none in 3 months

Developer of synbiotics for simulating gut microbiome

Microbiome therapeutics
US$40.62mSeries A · Apr 2021
3LinkedIn · Jul 2026
E-commerce - product / Physical commerce
10 yr2016
0none in 3 months

Manufactures vitamin supplements using encapsulation technology

Nutraceuticals tech
US$40.30mSeries B · Feb 2019
240+18% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product
11 yr2015
0none in 3 months · last posted Jul 2026

Internet-first brand offering multi-category nutritious products

Nutraceuticals tech
US$36.24mSeries B · Mar 2025
35LinkedIn · Jul 2026
E-commerce - product
7 yr2019
0none in 3 months · last posted Nov 2025

Developer of small molecule cancer therapeutics that target DNA replication and integrity

Life sciences platforms and tools
US$31.22mSeries C · Apr 2025
9LinkedIn · Jul 2026
E-commerce - product / Physical commerce
13 yr2013
0none in 3 months

Precision diagnostics for gastrointestinal diseases, leveraging microbiome discoveries for optimal treatment

Gastroenterology
US$23.03mSeries A · Dec 2021
24-21% vs previous recordLinkedIn · Jul 2026
Subscription
8 yr2018
0none in 3 months · last posted Mar 2026

Precision medicine company improving lives with mTOR-driven disease therapies

Oncology
US$23.00mSeries A · May 2017
59+631% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
18 yr2008
0none in 3 months

Provider of nutritional supplements for prenatal care

Nutraceuticals tech
US$22.60mSeries A · Sep 2023
136+20% vs previous recordLinkedIn · Jul 2026
E-commerce - product
9 yr2017
0none in 3 months

Manufacturer of prebiotic, probiotic, and algal extracts supplements

Nutraceuticals tech
US$22.26mSeries B · Apr 2019
55LinkedIn · Jul 2026
E-commerce - product
14 yr2012
0none in 3 months · last posted Aug 2025

Developer of a medical device for the treatment of spinal cord injuries

Neurology
US$22.00mSeries C · Mar 2026
30LinkedIn · Jul 2026
Physical commerce / Subscription
10 yr2016
0none in 3 months · last posted Oct 2025

Provider of nutritional beverages

Nutraceuticals tech
US$19.50mSeries B · Oct 2021
33LinkedIn · Jul 2026
E-commerce - product
11 yr2015
—No postings tracked

Cybersecurity and technology insights for a safer digital experience

Imaging diagnostics
US$19.35mSeries A · Feb 2016
50recorded
Physical commerce
15 yr2011
0none in 3 months

Developer of drug delivery methods for pharma-based therapeutics

Drug delivery
US$18.74mSeries A · Jul 2024
4recorded
Fee-for-service
18 yr2008
0none in 3 months
50 of 286 companies shown here · the full list is on Radar
Fliar Radar

Explore all 286 life sciences companies in Los Angeles on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Los Angeles on Radar
  • Every company, not just 50All 286 life sciences companies in Los Angeles, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Los Angeles by what you are looking for

Browse life sciences companies in Los Angeles, from genomics and oncology to medical devices and life science tools. Discover life science companies working on research, therapeutics and diagnostics.

8 ways to explore life sciences in Los Angeles

Life science platforms and toolsGenomics and genetic testing companiesOncology and cancer therapy companiesMedical device and diagnostic companiesNutraceutical and wellness companiesLife sciences startups in Los Angeles

Life science platforms and tools

Research platforms, instruments and tools for life sciences.

  1. Octant

    Provider of human cell interaction platform for drug discovery

    Genomics
    See in list
  2. Pictor Labs

    AI-based solutions for pathological image analysis

    Life sciences tech
    See in list
  3. Trethera

    Developer of small molecule cancer therapeutics that target DNA replication and integrity

    Life sciences platforms and tools
    See in list
  4. Sleuth Insights

    Provider of strategic insights for biopharma commercial diligence

    Life sciences tech
    See in list
  5. Sanguine

    Building a databank of patient-derived data for advanced research

    Data as a service
    See in list

Genomics and genetic testing companies

Life sciences companies focused on genomics and genetic analysis.

  1. C3J Therapeutics

    Developing phage therapeutics to combat antibiotic-resistant bacterial infections

    Infectious diseases
    See in list
  2. Octant

    Provider of human cell interaction platform for drug discovery

    Genomics
    See in list
  3. ImaginAb

    Immune imaging technology for cancer and autoimmune disease management

    Imaging diagnostics
    See in list
  4. Seed

    Developer of synbiotics for simulating gut microbiome

    Microbiome therapeutics
    See in list
  5. MicrobeDx

    Provider of the solutions for the detection of antibiotic susceptibility in urinary tract infections

    Genomics
    See in list

Oncology and cancer therapy companies

Life sciences companies developing cancer diagnostics and treatments.

  1. TORL BioTherapeutics

    Developer of antibody-based therapeutics for the treatment of cancer

    Oncology
    See in list
  2. Puma Biotechnology

    Developer of tyrosine kinase inhibitor for the treatment of breast cancer

    Women health
    See in list
  3. ImaginAb

    Immune imaging technology for cancer and autoimmune disease management

    Imaging diagnostics
    See in list
  4. Trethera

    Developer of small molecule cancer therapeutics that target DNA replication and integrity

    Life sciences platforms and tools
    See in list
  5. Fuse Biotherapeutics

    Developer of immune-modulating therapies for the treatment of cancer

    Immunotherapy
    See in list

Medical device and diagnostic companies

Developers of medical devices, monitoring systems and diagnostic technology.

  1. Kernel

    Developer of multimodal brain measurement technology for neuromedicine

    Wearable technology
    See in list
  2. Aneuvo

    Developer of a medical device for the treatment of spinal cord injuries

    Neurology
    See in list
  3. Sensydia

    Cardio-respiratory monitoring device

    Cardiac and vascular disorders
    See in list
  4. NeuroSigma

    Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders

    Neurology
    See in list
  5. Cubtale

    Provider of a device and app for monitoring babies

    Disease self management
    Website

Nutraceutical and wellness companies

Life sciences businesses developing supplements and nutritional products.

  1. Prolacta Bioscience

    Human milk-based nutrition for vulnerable infants, improving health outcomes

    Nutraceuticals tech
    See in list
  2. Needed

    Provider of nutritional supplements for prenatal care

    Nutraceuticals tech
    See in list
  3. HUM Nutrition

    Manufacturer of prebiotic, probiotic, and algal extracts supplements

    Nutraceuticals tech
    See in list
  4. More Labs

    Provider of nutritional beverages

    Nutraceuticals tech
    See in list
  5. Fount

    Provider of jet lag prevention and recovery kits for travelers. It offers a system combining patented supplements, blue-light blocking glasses, and an AI-driven app to synchronize circadian rhythms with new time zones. The kits are designed to minimize inflammation, boost energy, and improve sleep quality, enabling travelers to arrive feeling refreshed and ready for activities. The app provides customized plans for eating, sleeping, and supplement use, adapting to individual itineraries and preferences. Additional add-ons, such as compression socks and neuromuscular stimulators, further enhanc

    Fitness & wellness tech
    See in list

Life sciences startups in Los Angeles

Recently founded life sciences companies in Los Angeles.

  1. LighthouseAI

    Provider of software and services for pharmaceutical state licensing and compliance

    Grc software
    See in list
  2. Freedom Bio

    Developer of next-generation pharmaceuticals for neuropsychiatric conditions and substance use disorders

    Neurology
    See in list
  3. Fuse Biotherapeutics

    Developer of immune-modulating therapies for the treatment of cancer

    Immunotherapy
    See in list
  4. Illuminant

    Developer of a surgical navigation system using augmented reality technology

    Surgical instruments
    See in list
  5. Sleuth Insights

    Provider of strategic insights for biopharma commercial diligence

    Life sciences tech
    See in list
39 companies in Los Angeles

Life sciences companies hiring in Los Angeles

Life sciences companies in Los Angeles with hiring activity.

  1. Prolacta Bioscience

    Human milk-based nutrition for vulnerable infants, improving health outcomes

    Nutraceuticals tech
    See in list
  2. Puma Biotechnology

    Developer of tyrosine kinase inhibitor for the treatment of breast cancer

    Women health
    See in list
  3. MannKind Corp

    Developer of small-molecule drugs

    Drug delivery
    See in list
  4. Ritual

    Manufactures vitamin supplements using encapsulation technology

    Nutraceuticals tech
    See in list
  5. Supergut

    Internet-first brand offering multi-category nutritious products

    Nutraceuticals tech
    See in list
16 companies in Los Angeles

Public life sciences companies in Los Angeles

Life sciences companies in Los Angeles that are publicly listed.

  1. ACELYRIN

    Developer of drugs for immunology

    Immunology
    See in list
  2. Puma Biotechnology

    Developer of tyrosine kinase inhibitor for the treatment of breast cancer

    Women health
    See in list
  3. MannKind Corp

    Developer of small-molecule drugs

    Drug delivery
    See in list
  4. Aadi Bioscience

    Precision medicine company improving lives with mTOR-driven disease therapies

    Oncology
    See in list
  5. NeOnc Technologies

    Developer of drug delivery methods for pharma-based therapeutics

    Drug delivery
    See in list
22 companies in Los Angeles
Mobile reach

Top 5 life sciences apps from Los Angeles

The most-installed Android apps published by life sciences companies headquartered in Los Angeles — 903K installs between them. 5 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 5
RadarBrowse every life sciences company in Los Angeles on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Los Angeles compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, Los Angeles24

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in Los Angeles

15Acquisition
9Merger

Most active acquirers

  1. Alumis4
  2. Celera4
  3. Standard dental labs2
  4. MannKind Corporation2
  5. Concentra Biosciences2

Most acquired or merged

  1. Acelyrin7
  2. Scpharmaceuticals2
  3. Alumis2
  4. BRLIT Dental Laboratory1
  5. Celyn Therapeutics, Inc.1

Each deal appears in the events strip at the top of the page.

Industry landscape report

Life Sciences Industry Landscape of Los Angeles

The financials above are one chapter. The full life sciences landscape of Los Angeles maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Los Angeles

Life sciences funding in Los Angeles

79 life sciences companies in Los Angeles have recorded equity funding, US$2.49bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Los Angeles

Meet the people behind life sciences companies in Los Angeles. 186 of 286 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Los Angeles life sciences companies by sub-sector

The most common specialisations among life sciences companies in Los Angeles. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Explore more lists: nearby cities and other sectors in Los Angeles

183 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Los Angeles

Browse the Radar directory

Coming soon